David Shapiro

2013

In 2013, David Shapiro earned a total compensation of $1.5M as Chief Medical Officer and Executive Vice President, Development at Intercept Pharmaceuticals, a 4% increase compared to previous year.

Compensation breakdown

Bonus$249,500
Option Awards$717,750
Salary$377,000
Stock Awards$95,700
Other$14,874
Total$1,454,824

Shapiro received $717.8K in option awards, accounting for 49% of the total pay in 2013.

Shapiro also received $249.5K in bonus, $377K in salary, $95.7K in stock awards and $14.9K in other compensation.

Rankings

In 2013, David Shapiro's compensation ranked 5,070th out of 12,286 executives tracked by ExecPay. In other words, Shapiro earned more than 58.7% of executives.

ClassificationRankingPercentile
All
5,070
out of 12,286
59th
Division
Manufacturing
1,747
out of 4,612
62nd
Major group
Chemicals And Allied Products
502
out of 1,462
66th
Industry group
Drugs
356
out of 1,156
69th
Industry
Pharmaceutical Preparations
285
out of 890
68th
Source: SEC filing on June 20, 2016.

Shapiro's colleagues

We found three more compensation records of executives who worked with David Shapiro at Intercept Pharmaceuticals in 2013.

2013

Daniel Regan

Intercept Pharmaceuticals

Former Chief Commercial Officer

2013

Mark Pruzanski

Intercept Pharmaceuticals

Chief Executive Officer

2013

Barbara Duncan

Intercept Pharmaceuticals

Chief Financial Officer

You may also like